Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant

NCT03118661 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No accrual to the study

Conditions

HIV-1-infection

Interventions

OTHER: For Step 2: Structured treatment interruption
PROCEDURE: Peripheral blood draw

Sponsor

Washington University School of Medicine